Skip to main content

Find Clinical Trials

Home
Conditions
Multiple Sclerosis

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

291 public trials 23 recruiting studies

Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Sensori-motor Integration Training in Multiple Sclerosis

NCT01040117

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: S.S.O. di Riabilitazione dell'Ospedale Policlinico Verona, Italy

Section of Clinical Neurology, Department Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, Verona, Italy Verona, Italy

View Trial Details

Completed

Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis

NCT00241254

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +9 more
Locations: CH de la Cote Basque Bayonne, France

CHU Besançon Besançon, France

Hôpital Pellegrin, Département de neurologie Bordeaux, France

CHU Caen Caen, France

View all 26 locations

View Trial Details

Completed

Natalizumab Treatment of Progressive Multiple Sclerosis

NCT01077466

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations: Danish Multiple Sclerosis Center, Section 2082, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS

NCT00675883

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: University Hospital, London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).

NCT00337779

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Not specified

View Trial Details

Completed

Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b

NCT01111656

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Department of Neurology, Bern University Hospital, and University of Bern Bern, Canton of Bern, Switzerland

View Trial Details

Completed

A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.

NCT00203073

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

NCT00349193

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Not specified

View Trial Details

Completed

A Study for Patients With Relapsing Remitting Multiple Sclerosis

NCT00869986

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Military Medical Academy Sofia, Bulgaria

Silesian Medical School Katowice, Poland

Clinical City Hospital No. 11 Moscow, Russia

Clinical Center of Serbia Belgrade, Serbia

View Trial Details

Completed

Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo

NCT00668343

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Sanaz Ahmadi Tehran, Iran

View Trial Details